578 results on '"Saccardi, R."'
Search Results
2. Manipulation, and cryopreservation of autologous peripheral blood stem cell products in Italy: A survey by GITMO, SIDEM and GIIMA societies
3. Intense Immunosuppression Followed by Autologous Stem Cell Transplantation in Severe Multiple Sclerosis Cases
4. Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Working Party (ADWP) of the European Society of Bone and Marrow Transplantation (EBMT)
5. Haematopoietic stem cell transplantation for severe autoimmune diseases in children : a review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation
6. DOP057 ECCO-EBMT joint paper: autologous haematopoietic stem cell transplantation (AHSCT) in severe Crohn’s disease: Summary of the ECCO-EBMT joint review
7. Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients with COVID-19 Pneumonia: A Randomized Clinical Trial
8. Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners
9. JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvement
10. P932: ON-DEMAND PLERIXAFOR WITH CYCLOPHOSPHAMIDE AND G-CSF FOR HEMATOPOIETIC STEM-CELL MOBILIZATION IN MULTIPLE MYELOMA PATIENTS: FINAL RESULTS OF THE MOZOBL06877 STUDY
11. Correction: Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT (Bone Marrow Transplantation, (2022), 57, 3, (416-422), 10.1038/s41409-021-01553-x)
12. Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT (vol 57, pg 416, 2022)
13. Management of adults and children receiving CAR T- cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
14. Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations
15. purely myeloablative conditioning regimen in aggressive multiple sclerosis: two case reports: AB81
16. Transplant-Associated Thrombotic Microangiopathy (TA-TMA) in a patient with acute GVHD after allogeneic hematopoietic stem cell transplantation successfully treated with eculizumab: AB33
17. Erythropoietin in Bone Marrow Transplantation: Pathophysiology and Clinical Use
18. Comparative evaluation of biological HLA-DPB1 mismatch models for survival and graft versus host disease prediction after unrelated donor hematopoietic cell transplantation
19. SARS-CoV-2 was already circulating in Italy, in early December 2019
20. SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking
21. EBV-Associated Post-Transplant Lymphoproliferative Disease (PTLD) in Allogeneic Transplantation
22. Androgens and estrogens prevent rosiglitazone-induced adipogenesis in human mesenchymal stem cells
23. Politerapia con midollo osseo concentrato, “scaffold” e fattori di crescita autologhi per promuovere la guarigione nelle lesioni pseudotumorali ossee
24. Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis
25. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009
26. PLERIXAFOR RESCUE FOR PBSC POOR MOBILIZER PATIENTS. SINGLE CENTER STRATEGY ON 26 CONSECUTIVE PATIENTS: PH-AB201
27. VALGANCICLOVIR PROPHYLAXIS IN HIGH RISK CMV PATIENTS UNDERGOING UMBILICAL CORD BLOOD TRANSPLANTATION WITH MYELOABLATIVE CONDITIONING REGIMEN: PH-AB080
28. RETROSPECTIVE MONOCENTRIC ANALYSIS OF ALLOGENEIC STEM CELL TRANSPLANTATION IN CML PATIENTS IN 25 YEARS: THE “ERA TKI” EFFECT: PH-AB013
29. SAFE USE OF PLERIXAFOR® IN ASSOCIATION THERAPY WITH CYCLOPHOSPHAMIDE AND G-CSF FOR STEM CELLS MOBILIZATION IN AUTOIMMUNE DISEASE: A CASE REPORT OF SEVERE SYSTEMIC SCLEROSIS (SSC): PH-AB011
30. AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE AUTOIMMUNE DISEASES:ANALYSIS OF 97 PATIENTS FROM THE FRENCH REGISTRY. SFGM-TC AND EBMT: PH-P313
31. CMV AND EBV REACTIVATION AFTER AUTOLOGOUS HAEMOPOIETIC STEM CELL TRANSPLANTATION WITH BEAM CONDITIONING REGIMEN FOR MULTIPLE SCLEROSIS AND LYMPHOMA: A RETROSPECTIVE SINGLE CENTER CASE-CONTROL STUDY: PH-P311
32. AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN NEUROMYELITIS OPTICA: A RETROSPECTIVE STUDY OF THE EBMT AUTOIMMUNE DISEASES WORKING PARTY IN COLLABORATION WITH THE UNIVERSITY OF SAO PAOLO RIBEIRÃO PRETO BRAZIL: PH-P308
33. EVOLUTION, TRENDS AND LONG TERM OUTCOMES IN HAEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN AUTOIMMUNE DISEASES (ADS): A RETROSPECTIVE STUDY FROM THE AUTOIMMUNE DISEASES WORKING PARTY (ADWP) OF THE EBMT 1996-2013: PH-O080
34. Allogeneic hematopoietic SCT for patients with autoimmune diseases
35. Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis
36. Treatment of experimental esophagogastric myotomy with bone marrow mesenchymal stem cells in a rat model
37. Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells
38. Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases : updated guidelines and recommendations from the EBMT autoimmune diseases working party (ADWP) and the joint accreditation committee of EBMT and ISCT (JACIE)
39. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe
40. Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis
41. Autologous hematopoietic stem cell transplantation for autoimmune diseases
42. Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis
43. Hematopoietic stem cells for neovascularization and wound repair
44. Bone marrow mesenchymal stem cell characterization in severe multiple sclerosis patients treated with autologous haematopoietic stem cell transplantation: O286
45. Effect of volume reduction of cord blood units before storage on transplantation outcomes: a retrospective analysis of Eurocord-EBMT and Netcord: O195
46. Hematopoietic stem cell transplantation for multiple sclerosis: A retrospective multicenter study
47. Use of CFDA-SE for evaluating the in vitro proliferation pattern of human mesenchymal stem cells
48. Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation
49. HSCT for severe multiple sclerosis with BEAM/ATG: impact on female fertility: P1191
50. CMV and EBV reactivation in autologous haemopoietic stem cell transplantation for severe multiple sclerosis: P1190
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.